Recently, a federal court has ordered that the manufacturers of the diabetes drug Actos (pioglitazone hydrochloride, by Takeda Pharmaceutical Co. and Eli Lilly & Co.) pay $9 billion in damages when it was determined that these companies failed to warn the public of cancer risks associated with their medication.
Though some legal experts believe that this penalty will be lowered by appellate courts, this federal decision marks a turning point in a years-long struggle for compensation for damages caused by Actos. (Reuters notes that “The $9 billion in punitive damages awarded by the jury against Takeda and Eli Lilly exceed the $5 billion penalty that a jury in Alaska imposed on Exxon Mobil Corp for the Exxon Valdez oil spill in 1989.”)
For years, law firms around the country have been signing up clients injured by Actos to secure compensation from a settlement such as this, and it seems that day has come a bit closer.
Unfortunately, Actos manufacturers continued producing the drug in light of a huge number of scientific studies connecting Actos to cancer and liver damage without warning patients, and as such, the number of patients injured by the drug has likely increased rather than decreased while the scientific community concluded the drug is unacceptably dangerous.
Here are a few studies I’ve summarized linking Actos and bladder cancer:
If you or a loved one used Actos and suffered bladder cancer as a result, you may be entitled to significant financial compensation. For a free, no-obligation case consultation, contact our team of Actos bladder cancer lawyers at the information provided below. We have the experience, resources, and skills required to win the justice you deserve. Call today and see how we can help.
(855) 452 – 5529